Questions swirl after Trump’s GLP-1 pricing deal announcement
At a White House event Thursday, President Trump announced deals with drug makers Novo Nordisk and Eli Lilly to offer their popular GLP-1 obesity and diabetes drugs at lower prices for some Americans, namely some on Medicare and Medicaid plans. But questions linger about the significance of the deal. According to the announcement, Medicare and […]
Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call
On its third-quarter conference call held on Nov. 4, Pfizer PFE shed light on the two topics for which it has been in the news lately — the drug pricing deal with the Trump administration and the battle with Novo Nordisk NVO related to the Metsera MTSR buyout. Pfizer’s Metsera Buyout in Jeopardy? Pfizer is locked […]
Novo Nordisk, Lilly shares slip on US drug pricing deal
Shares in Novo Nordisk and Eli Lilly slipped on Friday after both agreed with the U.S government to lower prices of their blockbuster GLP-1 weight-loss drugs.
Weight-loss therapy goes pill-to-shot with higher efficacy, convenience
Sales of Novo Nordisk’s oral weight-loss drug Rybelsus have plateaued as Indians increasingly shift to injectable GLP-1 drugs like Eli Lilly’s Mounjaro, which has captured ₹450 crore in seven months. Injectables offer higher efficacy and convenience, though experts expect orals to rebound once higher-dose, cheaper versions launch post-2026.
Weight loss jabs are suppressing our appetite for adventure…
GLP-1 drugs inhibit not just hunger but also pleasure-seeking impulses, causing surprising changes to our habits
Novo Nordisk shares dip after obesity drug price deal | REUTERS
Shares in Novo Nordisk fell as much as 3% after the Danish drugmaker and US rival Eli Lilly agreed with the US government to lower prices of their blockbuster GLP-1 weight-loss drugs. #News #Reuters #Newsfeed Read the story here: https://reut.rs/4nJ11dF 👉 Subscribe: http://smarturl.it/reuterssubscribe Keep up with the latest news from around the world: https://www.reuters.com/ Follow […]
🎥 Tufts MD on GLP-1 and the protein obsession: ‘I worry we might be missing the mark’
Protein is hot. And the GLP-1 trend is only accelerating it, with firms competing to come up with ever more soluble and better absorbed options enabling brands to pack ever greater amounts into everything from protein water to drinkable yogurt. Loss of lean muscle mass is a well-publicized issue for people that rapidly lose weight […]
Trump Unveils Deals To Lower Costs Of Some weight-Loss Drugs
WASHINGTON:�US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs, in exchange for relief from threatened tariffs. Both companies “have agreed to offer their most popular GLP-1 weight-loss drug,” Trump said at the White House, “at drastic discounts.””Eli Lilly and Novo […]
Eli Lilly, Novo Nordisk’s Historic GLP-1 Pricing Deals – What Investors Need To Know
Post Content
Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs
CEO Sean Duffy cofounded Omada Health in 2011. Omada Health Trump said Thursday that TrumpRx would offer discounts on GLP-1 drugs for weight loss. A few hours later, Omada Health said it will prescribe the drugs starting in 2026. The diabetes company previously stayed out of GLP-1 prescribing amid the Ozempic frenzy. A billion-dollar diabetes […]